DK0584552T3 - Chlorophyl- og bakteriochlorophylderivater, deres fremstilling og farmaceutiske sammensætninger omfattende dem - Google Patents
Chlorophyl- og bakteriochlorophylderivater, deres fremstilling og farmaceutiske sammensætninger omfattende demInfo
- Publication number
- DK0584552T3 DK0584552T3 DK93111942T DK93111942T DK0584552T3 DK 0584552 T3 DK0584552 T3 DK 0584552T3 DK 93111942 T DK93111942 T DK 93111942T DK 93111942 T DK93111942 T DK 93111942T DK 0584552 T3 DK0584552 T3 DK 0584552T3
- Authority
- DK
- Denmark
- Prior art keywords
- derivatives
- chl
- conjugates
- bchl
- bacteriochlorophyl
- Prior art date
Links
- 235000019804 chlorophyll Nutrition 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 4
- 150000001413 amino acids Chemical class 0.000 abstract 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 abstract 2
- 238000002428 photodynamic therapy Methods 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108010003118 Bacteriochlorophylls Proteins 0.000 abstract 1
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 abstract 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 abstract 1
- DSJXIQQMORJERS-AGGZHOMASA-M bacteriochlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC([C@H](CC)[C@H]3C)=[N+]4C3=CC3=C(C(C)=O)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 DSJXIQQMORJERS-AGGZHOMASA-M 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 229930002875 chlorophyll Natural products 0.000 abstract 1
- 230000021615 conjugation Effects 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 239000003504 photosensitizing agent Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- C07K14/685—Alpha-melanotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Radiation-Therapy Devices (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL102645A IL102645A (en) | 1992-07-26 | 1992-07-26 | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0584552T3 true DK0584552T3 (da) | 2001-02-05 |
Family
ID=11063865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93111942T DK0584552T3 (da) | 1992-07-26 | 1993-07-26 | Chlorophyl- og bakteriochlorophylderivater, deres fremstilling og farmaceutiske sammensætninger omfattende dem |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US5726169A (hu) |
| EP (1) | EP0584552B1 (hu) |
| JP (1) | JP3612343B2 (hu) |
| CN (1) | CN1040212C (hu) |
| AT (1) | ATE196850T1 (hu) |
| AU (1) | AU674315B2 (hu) |
| CA (1) | CA2101227C (hu) |
| DE (1) | DE69329538T2 (hu) |
| DK (1) | DK0584552T3 (hu) |
| ES (1) | ES2153367T3 (hu) |
| GR (1) | GR3035195T3 (hu) |
| HU (1) | HU221186B1 (hu) |
| IL (1) | IL102645A (hu) |
| PL (2) | PL173128B1 (hu) |
| PT (1) | PT584552E (hu) |
| ZA (1) | ZA935310B (hu) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6147195A (en) * | 1993-07-26 | 2000-11-14 | Yeda Research And Development Co., Ltd. | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| IL116126A0 (en) | 1995-11-24 | 1996-01-31 | Yeda Res & Dev | Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them |
| GB9625895D0 (en) * | 1996-12-13 | 1997-01-29 | Riley Patrick A | Novel compound useful as therapeutic agents and assay reagents |
| CN1074771C (zh) * | 1996-12-30 | 2001-11-14 | 中国科学院长春应用化学研究所 | 聚合物载体茂金属催化剂的制备 |
| AU6028598A (en) * | 1997-01-09 | 1998-08-03 | Emory University | Non-iron metalloporphyrins and methods of use |
| DE19731741A1 (de) * | 1997-07-23 | 1999-01-28 | Deutsches Krebsforsch | Konjugat zur Unterscheidung von krankhaftem und gesundem Gewebe |
| US6299860B1 (en) | 1998-10-15 | 2001-10-09 | Fluoro Probe, Inc. | Method for viewing diseased tissue located within a body cavity |
| US6652836B2 (en) | 1998-10-15 | 2003-11-25 | Fluoroprobe, Inc. | Method for viewing tumor tissue located within a body cavity |
| US6284223B1 (en) * | 1998-10-15 | 2001-09-04 | Fluoroprobe, Inc. | Method for viewing tumor tissue located within a body cavity |
| CN1160069C (zh) | 1998-12-09 | 2004-08-04 | 耶达研究及发展有限公司 | 钯取代的细菌叶绿素衍生物及其应用 |
| US7045117B2 (en) * | 1999-12-01 | 2006-05-16 | Yeda Research And Development Co. Ltd. | Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives |
| IL133253A0 (en) | 1999-12-01 | 2001-04-30 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| JP2003519670A (ja) * | 2000-01-12 | 2003-06-24 | ライト サイエンシーズ コーポレイション | 眼疾患の新規処置 |
| US7235685B2 (en) | 2001-07-03 | 2007-06-26 | Mallinckrodt, Inc. | Aromatic sulfenates for type I phototherapy |
| US20020169107A1 (en) * | 2001-01-19 | 2002-11-14 | Mallinckrodt Inc. | Novel aromatic azides for type I phototherapy |
| AU7570201A (en) * | 2000-07-26 | 2002-02-05 | Riley Patrick Anthony | Phenylethylamine derivatives and their use in the treatment of melanoma |
| WO2002013820A1 (en) * | 2000-08-11 | 2002-02-21 | Ceramoptec Industries, Inc. | Photosensitizing ointment |
| AU2006200164B2 (en) * | 2001-04-09 | 2007-03-08 | Oncofluor, Inc. | Method for viewing tumor tissue located within a body cavity |
| IL148921A0 (en) * | 2002-03-26 | 2002-09-12 | Peptor Ltd | Photo active backbone cyclized somatostatin analogs for optical imaging and photodynamic therapy |
| AU2003230164B2 (en) | 2002-05-08 | 2008-05-01 | Yeda Research And Development Co. Ltd. | Sensitized online BOLD-MRI imaging method |
| IL152900A0 (en) * | 2002-11-17 | 2003-06-24 | Yeda Res & Dev | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
| GB0323358D0 (en) * | 2003-10-06 | 2003-11-05 | Green Grass Design Ltd | Novel compounds and processes |
| ZA200700169B (en) | 2004-06-07 | 2008-05-28 | Yeda Res & Dev | Cationic bacteriochlorophyll derivatives and uses thereof |
| US7947827B2 (en) * | 2006-06-30 | 2011-05-24 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use |
| US9957293B2 (en) | 2006-08-23 | 2018-05-01 | Yeda Research And Development Company Ltd. | Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| ES2763237T3 (es) * | 2006-08-23 | 2020-05-27 | Yeda Res & Dev | Conjugados de péptidos de RGD y fotosensibilizantes de (bacterio)clorofila y sus usos |
| JP2010538798A (ja) | 2007-09-19 | 2010-12-16 | オンコフルーア インコーポレイテッド | 臓器および組織を撮像および処置するための方法 |
| FR2924021B1 (fr) * | 2007-11-27 | 2010-08-13 | Du Vernet Michele Eymard | Composition pour le traitement de la peau par therapie photodynamique |
| WO2009095912A1 (en) * | 2008-01-28 | 2009-08-06 | Yeda Research And Development Co. Ltd | Endoscopic imaging photodynamic therapy system and methods of use |
| WO2009103816A1 (en) * | 2008-02-22 | 2009-08-27 | Clinuvel Pharmaceuticals Limited | Method for treatment of photosensitivity and phototoxicity |
| BRPI0907791A2 (pt) | 2008-02-27 | 2015-08-04 | Yeda Res & Dev | Conjugados rgd-(bacterio)clorofila para terapia fotodinâmica e formação de imagem de tumores necróticos |
| IN2014CN02153A (hu) | 2011-08-23 | 2015-05-29 | Yeda Res & Dev | |
| ES2764090T3 (es) * | 2012-12-19 | 2020-06-02 | Univ New York State Res Found | Composiciones y procedimiento para la liberación activada por la luz de materiales de nanovesículas |
| BR112015030233A2 (pt) * | 2013-06-05 | 2017-07-25 | Hafezi Farhad | método de aplicação de uma composição e composição farmacêutica com um regime de administração da mesma |
| RU2536116C1 (ru) * | 2013-07-25 | 2014-12-20 | федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ фотодинамической обработки склерального ложа после эндорезекции внутриглазного новообразования |
| RU2536109C1 (ru) * | 2013-07-25 | 2014-12-20 | федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ комбинированной обработки склерального ложа после эндорезекции внутриглазного новообразования |
| SG10201506686WA (en) * | 2015-08-24 | 2017-03-30 | Agency Science Tech & Res | Conjugates |
| CN111171030B (zh) * | 2018-11-12 | 2022-11-22 | 浙江海正药业股份有限公司 | 细菌叶绿素衍生物及其制备方法 |
| CN115093422B (zh) * | 2022-06-15 | 2023-06-20 | 西北工业大学 | 一种基于代谢标记策略的新型光敏剂及其制备方法和应用 |
| CN116585530B (zh) * | 2023-05-05 | 2024-02-02 | 暨南大学 | 一种高效产氧的叶绿体复合水凝胶及其制备方法与应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5156840A (en) * | 1982-03-09 | 1992-10-20 | Cytogen Corporation | Amine-containing porphyrin derivatives |
| US4977177A (en) * | 1985-04-30 | 1990-12-11 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
| HU204856B (en) * | 1987-08-12 | 1992-02-28 | Orszagos Mueszaki Fejlesztesi | Process for releasing cell mixtures and tissues from undesired populations and for producing monoclonal antibody - hematoporphyrin conjugates |
| US4876190A (en) * | 1987-10-21 | 1989-10-24 | Becton Dickinson & Company | Peridinin-chlorophyll complex as fluorescent label |
| EP0350948B1 (en) * | 1988-07-14 | 1998-03-18 | Toyohakka Kogyo Kabushiki Kaisha | Porphyrin derivatives |
| US5002962A (en) * | 1988-07-20 | 1991-03-26 | Health Research, Inc. | Photosensitizing agents |
| US5567687A (en) * | 1989-03-06 | 1996-10-22 | University Of Texas | Texaphyrins and uses thereof |
| US5171741A (en) * | 1989-04-21 | 1992-12-15 | Health Research, Inc. | Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
| US5238940A (en) * | 1990-03-22 | 1993-08-24 | Quadra Logic Technologies Inc. | Compositions for photodynamic therapy |
| DE4121876A1 (de) * | 1991-07-02 | 1993-01-14 | Scheer Hugo | Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung |
| US5330741A (en) * | 1992-02-24 | 1994-07-19 | The Regents Of The University Of California | Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors |
-
1992
- 1992-07-26 IL IL102645A patent/IL102645A/en not_active IP Right Cessation
-
1993
- 1993-07-22 AU AU42148/93A patent/AU674315B2/en not_active Ceased
- 1993-07-22 ZA ZA935310A patent/ZA935310B/xx unknown
- 1993-07-23 HU HU9302149A patent/HU221186B1/hu not_active IP Right Cessation
- 1993-07-23 CA CA002101227A patent/CA2101227C/en not_active Expired - Fee Related
- 1993-07-26 ES ES93111942T patent/ES2153367T3/es not_active Expired - Lifetime
- 1993-07-26 JP JP22632893A patent/JP3612343B2/ja not_active Expired - Fee Related
- 1993-07-26 DE DE69329538T patent/DE69329538T2/de not_active Expired - Fee Related
- 1993-07-26 CN CN93116862A patent/CN1040212C/zh not_active Expired - Fee Related
- 1993-07-26 EP EP93111942A patent/EP0584552B1/en not_active Expired - Lifetime
- 1993-07-26 AT AT93111942T patent/ATE196850T1/de not_active IP Right Cessation
- 1993-07-26 US US08/097,384 patent/US5726169A/en not_active Expired - Fee Related
- 1993-07-26 PL PL93319910A patent/PL173128B1/pl not_active IP Right Cessation
- 1993-07-26 PL PL93299803A patent/PL173150B1/pl not_active IP Right Cessation
- 1993-07-26 DK DK93111942T patent/DK0584552T3/da active
- 1993-07-26 PT PT93111942T patent/PT584552E/pt unknown
-
1995
- 1995-06-05 US US08/461,243 patent/US5955585A/en not_active Expired - Fee Related
- 1995-07-31 US US08/463,950 patent/US5650292A/en not_active Expired - Fee Related
-
2001
- 2001-01-10 GR GR20010400013T patent/GR3035195T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3612343B2 (ja) | 2005-01-19 |
| PL173150B1 (pl) | 1998-01-30 |
| EP0584552B1 (en) | 2000-10-11 |
| US5955585A (en) | 1999-09-21 |
| IL102645A (en) | 1998-02-22 |
| AU674315B2 (en) | 1996-12-19 |
| CN1088210A (zh) | 1994-06-22 |
| PL299803A1 (en) | 1994-02-07 |
| PL173128B1 (pl) | 1998-01-30 |
| GR3035195T3 (en) | 2001-04-30 |
| JPH0733772A (ja) | 1995-02-03 |
| PT584552E (pt) | 2001-04-30 |
| CA2101227A1 (en) | 1994-01-27 |
| HUT64949A (en) | 1994-03-28 |
| HU221186B1 (en) | 2002-08-28 |
| US5726169A (en) | 1998-03-10 |
| AU4214893A (en) | 1994-01-27 |
| IL102645A0 (en) | 1993-01-14 |
| CA2101227C (en) | 2002-11-12 |
| ZA935310B (en) | 1994-02-11 |
| ES2153367T3 (es) | 2001-03-01 |
| EP0584552A2 (en) | 1994-03-02 |
| ATE196850T1 (de) | 2000-10-15 |
| EP0584552A3 (en) | 1994-08-17 |
| CN1040212C (zh) | 1998-10-14 |
| DE69329538D1 (de) | 2000-11-16 |
| HU9302149D0 (en) | 1993-10-28 |
| US5650292A (en) | 1997-07-22 |
| DE69329538T2 (de) | 2001-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0584552T3 (da) | Chlorophyl- og bakteriochlorophylderivater, deres fremstilling og farmaceutiske sammensætninger omfattende dem | |
| ES2736505T3 (es) | Nuevo conjugado estable de anticuerpo-fármaco, método de preparación y uso del mismo | |
| US6217873B1 (en) | Polyoxime compounds and their preparation | |
| WO1988000837A2 (en) | Advanced anticancer therapy and cytotoxic medicaments for its implementation | |
| DK0662827T3 (da) | Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer | |
| RU2009130954A (ru) | Применение белков теплового шока для улучшения терапевтического эффекта невакционного лечебного воздействия | |
| NO891711L (no) | Hiv env-kodet peptid som er istand til aa fremkalle hiv-inhiberende antistoffer i pattedyr. | |
| CY1105701T1 (el) | Μεθοδος δια την παρασκευη ενος ενεσιμου φαρμακευτικου σκευασματος | |
| HUT70471A (en) | Antitumor imunoconjugates, method for producing them, and pharmaceutical compositions containing the conjugates | |
| CY1107047T1 (el) | Παραγωγα δολαστατινης 15 | |
| DE19926475A1 (de) | Träger-Pharmaka-Konjugate | |
| DE602006017667D1 (de) | Cysteinhaltiges peptid-tag zur stellenspezifischen konjugation von proteinen | |
| DK1246826T3 (da) | Chlorophyl- og bakteriochlorophylestere, deres fremstilling og farmaceutiske præparater omfattende disse estere | |
| NZ504938A (en) | Tumor antigen peptide derivatives capable of binding to HLA-A24 antigen | |
| KR20180081494A (ko) | 암의 표적화 치료를 위한 광역학 치료제의 합성 및 조성물 | |
| EP2046813B1 (de) | Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel | |
| US6663869B1 (en) | Polyoxime compounds and their preparation | |
| WO1991000111A1 (en) | Targetting agents | |
| AU635721B2 (en) | Targetting agents | |
| ES2326530T3 (es) | Citocinas modificadas para su utilizacion en la terapia del cancer. | |
| DE60019725D1 (de) | Verwendung eines mit dem peptid "elagigiltv" assoziierten enterobakterien-proteins ompa zur behandlung von melanomen | |
| ES2360203T3 (es) | Ligación química "seudo"- natural. | |
| DK549589D0 (da) | Neoglycoproteiner, deres fremstilling og anvendelse | |
| DK0584118T3 (da) | Nyt konjugat, bestående af et glycoprotein og en nucleinsyrebindende substans | |
| AU2002362210A1 (en) | Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |